Fanapt
- Product NDC
- 69189-0665
- 11-digit product format
- 691890665
- Labeler code
- 69189
- Product ID
- 69189-0665_9cfe65cc-b53f-4931-b5ed-ad695227ee97
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- iloperidone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Avera McKennan Hospital
- Application
- NDA022192
- Marketing category
- NDA
- Marketing start
- 2016-07-01
- Marketing end
- 0000-00-00
- Substance
- ILOPERIDONE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 69189-0665 | I | Inactivated by FDA | 2026-08-17 | ||
| excluded package | package | 69189-0665 | 69189-0665-1 | I | Inactivated by FDA | 2026-08-17 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 69189-0665-1 | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 69189-0665-1 | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 69189-0665-1 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 69189-0665-1 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 69189-0665-1 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 69189-0665-1 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | I | Inactivated by FDA | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 69189-0665-1 | I | Inactivated by FDA | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | I | Inactivated by FDA | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 69189-0665-1 | I | Inactivated by FDA | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | I | Inactivated by FDA | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 69189-0665-1 | I | Inactivated by FDA | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | I | Inactivated by FDA | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 69189-0665-1 | I | Inactivated by FDA | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | I | Inactivated by FDA | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 69189-0665-1 | I | Inactivated by FDA | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | I | Inactivated by FDA | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 69189-0665-1 | I | Inactivated by FDA | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | I | Inactivated by FDA | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 69189-0665-1 | I | Inactivated by FDA | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | I | Inactivated by FDA | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 69189-0665-1 | I | Inactivated by FDA | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | I | Inactivated by FDA | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 69189-0665-1 | I | Inactivated by FDA | 1332a3947898… | d4bfe170f9cd… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | I | Inactivated by FDA | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 69189-0665-1 | I | Inactivated by FDA | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 69189-0665-1 | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 69189-0665-1 | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | I | Inactivated by FDA | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 69189-0665-1 | I | Inactivated by FDA | 8dfbde2a14a4… | c9ff85d89658… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 69189-0665-1 | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 69189-0665-1 | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded product | product | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… | |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded package | package | 69189-0665-1 | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022192-001 | FANAPT | ILOPERIDONE | 1MG | TABLET / ORAL | RLD, RS | 2009-05-06 | |
| N022192-002 | FANAPT | ILOPERIDONE | 2MG | TABLET / ORAL | RLD | 2009-05-06 | |
| N022192-003 | FANAPT | ILOPERIDONE | 4MG | TABLET / ORAL | RLD | 2009-05-06 | |
| N022192-004 | FANAPT | ILOPERIDONE | 6MG | TABLET / ORAL | RLD | 2009-05-06 | |
| N022192-005 | FANAPT | ILOPERIDONE | 8MG | TABLET / ORAL | RLD | 2009-05-06 | |
| N022192-006 | FANAPT | ILOPERIDONE | 10MG | TABLET / ORAL | RLD | 2009-05-06 | |
| N022192-007 | FANAPT | ILOPERIDONE | 12MG | TABLET / ORAL | RLD | 2009-05-06 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N022192-001 | 8586610 | 2027-11-02 | U-1625 | 2015-01-08 | |
| N022192-001 | 10570453 | 2028-03-28 | U-4562 | 2026-07-09 | |
| N022192-001 | 10570453 | 2028-03-28 | U-4563 | 2026-07-09 | |
| N022192-001 | 9157121 | 2030-04-05 | U-1674 | 2015-10-13 | |
| N022192-001 | 10563259 | 2030-07-24 | U-4562 | 2026-07-09 | |
| N022192-001 | 10563259 | 2030-07-24 | U-4563 | 2026-07-09 | |
| N022192-001 | 8652776 | 2030-08-31 | U-1685 | 2015-04-30 | |
| N022192-001 | 12606869 | 2030-09-22 | U-4504 | 2026-05-21 | |
| N022192-001 | 12606869 | 2030-09-22 | U-4505 | 2026-05-21 | |
| N022192-001 | 8999638 | 2030-10-28 | U-1674 | 2015-04-07 | |
| N022192-001 | 9074255 | 2030-12-17 | U-1674 | 2015-07-28 | |
| N022192-001 | 9072742 | 2031-01-16 | U-1674 | 2015-07-28 | |
| N022192-001 | 9074256 | 2031-02-10 | U-1674 | 2015-07-28 | |
| N022192-001 | 9074254 | 2031-12-28 | U-1674 | 2015-07-28 | |
| N022192-002 | 8586610 | 2027-11-02 | U-1625 | 2015-01-08 | |
| N022192-002 | 10570453 | 2028-03-28 | U-4562 | 2026-07-09 | |
| N022192-002 | 10570453 | 2028-03-28 | U-4563 | 2026-07-09 | |
| N022192-002 | 9157121 | 2030-04-05 | U-1674 | 2015-10-13 | |
| N022192-002 | 10563259 | 2030-07-24 | U-4562 | 2026-07-09 | |
| N022192-002 | 10563259 | 2030-07-24 | U-4563 | 2026-07-09 | |
| N022192-002 | 8652776 | 2030-08-31 | U-1685 | 2015-04-30 | |
| N022192-002 | 12606869 | 2030-09-22 | U-4504 | 2026-05-21 | |
| N022192-002 | 12606869 | 2030-09-22 | U-4505 | 2026-05-21 | |
| N022192-002 | 8999638 | 2030-10-28 | U-1674 | 2015-04-07 | |
| N022192-002 | 9074255 | 2030-12-17 | U-1674 | 2015-07-28 | |
| N022192-002 | 9072742 | 2031-01-16 | U-1674 | 2015-07-28 | |
| N022192-002 | 9074256 | 2031-02-10 | U-1674 | 2015-07-28 | |
| N022192-002 | 9074254 | 2031-12-28 | U-1674 | 2015-07-28 | |
| N022192-003 | 8586610 | 2027-11-02 | U-1625 | 2015-01-08 | |
| N022192-003 | 10570453 | 2028-03-28 | U-4562 | 2026-07-09 | |
| N022192-003 | 10570453 | 2028-03-28 | U-4563 | 2026-07-09 | |
| N022192-003 | 9157121 | 2030-04-05 | U-1674 | 2015-10-13 | |
| N022192-003 | 10563259 | 2030-07-24 | U-4562 | 2026-07-09 | |
| N022192-003 | 10563259 | 2030-07-24 | U-4563 | 2026-07-09 | |
| N022192-003 | 8652776 | 2030-08-31 | U-1685 | 2015-04-30 | |
| N022192-003 | 12606869 | 2030-09-22 | U-4504 | 2026-05-21 | |
| N022192-003 | 12606869 | 2030-09-22 | U-4505 | 2026-05-21 | |
| N022192-003 | 8999638 | 2030-10-28 | U-1674 | 2015-04-07 | |
| N022192-003 | 9074255 | 2030-12-17 | U-1674 | 2015-07-28 | |
| N022192-003 | 9072742 | 2031-01-16 | U-1674 | 2015-07-28 | |
| N022192-003 | 9074256 | 2031-02-10 | U-1674 | 2015-07-28 | |
| N022192-003 | 9074254 | 2031-12-28 | U-1674 | 2015-07-28 | |
| N022192-004 | 8586610 | 2027-11-02 | U-1625 | 2015-01-08 | |
| N022192-004 | 10570453 | 2028-03-28 | U-4562 | 2026-07-09 | |
| N022192-004 | 10570453 | 2028-03-28 | U-4563 | 2026-07-09 | |
| N022192-004 | 9157121 | 2030-04-05 | U-1674 | 2015-10-13 | |
| N022192-004 | 10563259 | 2030-07-24 | U-4562 | 2026-07-09 | |
| N022192-004 | 10563259 | 2030-07-24 | U-4563 | 2026-07-09 | |
| N022192-004 | 8652776 | 2030-08-31 | U-1685 | 2015-04-30 | |
| N022192-004 | 12606869 | 2030-09-22 | U-4504 | 2026-05-21 | |
| N022192-004 | 12606869 | 2030-09-22 | U-4505 | 2026-05-21 | |
| N022192-004 | 8999638 | 2030-10-28 | U-1674 | 2015-04-07 | |
| N022192-004 | 9074255 | 2030-12-17 | U-1674 | 2015-07-28 | |
| N022192-004 | 9072742 | 2031-01-16 | U-1674 | 2015-07-28 | |
| N022192-004 | 9074256 | 2031-02-10 | U-1674 | 2015-07-28 | |
| N022192-004 | 9074254 | 2031-12-28 | U-1674 | 2015-07-28 | |
| N022192-005 | 8586610 | 2027-11-02 | U-1625 | 2015-01-08 | |
| N022192-005 | 10570453 | 2028-03-28 | U-4562 | 2026-07-09 | |
| N022192-005 | 10570453 | 2028-03-28 | U-4563 | 2026-07-09 | |
| N022192-005 | 9157121 | 2030-04-05 | U-1674 | 2015-10-13 | |
| N022192-005 | 10563259 | 2030-07-24 | U-4562 | 2026-07-09 | |
| N022192-005 | 10563259 | 2030-07-24 | U-4563 | 2026-07-09 | |
| N022192-005 | 8652776 | 2030-08-31 | U-1685 | 2015-04-30 | |
| N022192-005 | 12606869 | 2030-09-22 | U-4504 | 2026-05-21 | |
| N022192-005 | 12606869 | 2030-09-22 | U-4505 | 2026-05-21 | |
| N022192-005 | 8999638 | 2030-10-28 | U-1674 | 2015-04-07 | |
| N022192-005 | 9074255 | 2030-12-17 | U-1674 | 2015-07-28 | |
| N022192-005 | 9072742 | 2031-01-16 | U-1674 | 2015-07-28 | |
| N022192-005 | 9074256 | 2031-02-10 | U-1674 | 2015-07-28 | |
| N022192-005 | 9074254 | 2031-12-28 | U-1674 | 2015-07-28 | |
| N022192-006 | 8586610 | 2027-11-02 | U-1625 | 2015-01-08 | |
| N022192-006 | 10570453 | 2028-03-28 | U-4562 | 2026-07-09 | |
| N022192-006 | 10570453 | 2028-03-28 | U-4563 | 2026-07-09 | |
| N022192-006 | 9157121 | 2030-04-05 | U-1674 | 2015-10-13 | |
| N022192-006 | 10563259 | 2030-07-24 | U-4562 | 2026-07-09 | |
| N022192-006 | 10563259 | 2030-07-24 | U-4563 | 2026-07-09 | |
| N022192-006 | 8652776 | 2030-08-31 | U-1685 | 2015-04-30 | |
| N022192-006 | 12606869 | 2030-09-22 | U-4504 | 2026-05-21 | |
| N022192-006 | 12606869 | 2030-09-22 | U-4505 | 2026-05-21 | |
| N022192-006 | 8999638 | 2030-10-28 | U-1674 | 2015-04-07 |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N022192-001 | I-939 | 2027-04-02 |
| N022192-002 | I-939 | 2027-04-02 |
| N022192-003 | I-939 | 2027-04-02 |
| N022192-004 | I-939 | 2027-04-02 |
| N022192-005 | I-939 | 2027-04-02 |
| N022192-006 | I-939 | 2027-04-02 |
| N022192-007 | I-939 | 2027-04-02 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N022192-001 | FANAPT | 1MG | TABLET / ORAL | RLD, RS | 2009-05-06 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-002 | FANAPT | 2MG | TABLET / ORAL | RLD | 2009-05-06 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-003 | FANAPT | 4MG | TABLET / ORAL | RLD | 2009-05-06 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-004 | FANAPT | 6MG | TABLET / ORAL | RLD | 2009-05-06 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-005 | FANAPT | 8MG | TABLET / ORAL | RLD | 2009-05-06 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-006 | FANAPT | 10MG | TABLET / ORAL | RLD | 2009-05-06 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-007 | FANAPT | 12MG | TABLET / ORAL | RLD | 2009-05-06 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022192-001 | FANAPT | 1MG | TABLET / ORAL | RLD, RS | 2009-05-06 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022192-002 | FANAPT | 2MG | TABLET / ORAL | RLD | 2009-05-06 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022192-003 | FANAPT | 4MG | TABLET / ORAL | RLD | 2009-05-06 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022192-004 | FANAPT | 6MG | TABLET / ORAL | RLD | 2009-05-06 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022192-005 | FANAPT | 8MG | TABLET / ORAL | RLD | 2009-05-06 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022192-006 | FANAPT | 10MG | TABLET / ORAL | RLD | 2009-05-06 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022192-007 | FANAPT | 12MG | TABLET / ORAL | RLD | 2009-05-06 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022192-001 | FANAPT | 1MG | TABLET / ORAL | RLD, RS | 2009-05-06 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022192-002 | FANAPT | 2MG | TABLET / ORAL | RLD | 2009-05-06 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022192-003 | FANAPT | 4MG | TABLET / ORAL | RLD | 2009-05-06 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022192-004 | FANAPT | 6MG | TABLET / ORAL | RLD | 2009-05-06 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022192-005 | FANAPT | 8MG | TABLET / ORAL | RLD | 2009-05-06 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022192-006 | FANAPT | 10MG | TABLET / ORAL | RLD | 2009-05-06 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022192-007 | FANAPT | 12MG | TABLET / ORAL | RLD | 2009-05-06 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022192-001 | FANAPT | 1MG | TABLET / ORAL | RLD, RS | 2009-05-06 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022192-002 | FANAPT | 2MG | TABLET / ORAL | RLD | 2009-05-06 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022192-003 | FANAPT | 4MG | TABLET / ORAL | RLD | 2009-05-06 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022192-004 | FANAPT | 6MG | TABLET / ORAL | RLD | 2009-05-06 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022192-005 | FANAPT | 8MG | TABLET / ORAL | RLD | 2009-05-06 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022192-006 | FANAPT | 10MG | TABLET / ORAL | RLD | 2009-05-06 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022192-007 | FANAPT | 12MG | TABLET / ORAL | RLD | 2009-05-06 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022192-001 | FANAPT | 1MG | TABLET / ORAL | RLD, RS | 2009-05-06 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022192-002 | FANAPT | 2MG | TABLET / ORAL | RLD | 2009-05-06 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022192-003 | FANAPT | 4MG | TABLET / ORAL | RLD | 2009-05-06 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022192-004 | FANAPT | 6MG | TABLET / ORAL | RLD | 2009-05-06 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022192-005 | FANAPT | 8MG | TABLET / ORAL | RLD | 2009-05-06 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022192-006 | FANAPT | 10MG | TABLET / ORAL | RLD | 2009-05-06 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022192-007 | FANAPT | 12MG | TABLET / ORAL | RLD | 2009-05-06 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022192-001 | FANAPT | 1MG | TABLET / ORAL | RLD, RS | 2009-05-06 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022192-002 | FANAPT | 2MG | TABLET / ORAL | RLD | 2009-05-06 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022192-003 | FANAPT | 4MG | TABLET / ORAL | RLD | 2009-05-06 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022192-004 | FANAPT | 6MG | TABLET / ORAL | RLD | 2009-05-06 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022192-005 | FANAPT | 8MG | TABLET / ORAL | RLD | 2009-05-06 | b8a1b40f171c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022192-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022192-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022192-003 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022192-004 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022192-005 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022192-006 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022192-007 | AB | 1 | 5c6f7cd8ea54… |
| 2019-07-19 19:46 UTC | 2019-07 | N022192-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N022192-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N022192-003 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N022192-004 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N022192-005 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N022192-006 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N022192-007 | AB | 1 | ea99ee380514… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N022192-001 | AB | 1 | cb3db0bc1861… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N022192-002 | AB | 1 | cb3db0bc1861… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N022192-003 | AB | 1 | cb3db0bc1861… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N022192-004 | AB | 1 | cb3db0bc1861… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N022192-005 | AB | 1 | cb3db0bc1861… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N022192-006 | AB | 1 | cb3db0bc1861… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N022192-007 | AB | 1 | cb3db0bc1861… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N022192-001 | 8586610 | 2027-11-02 | U-1625 | 2015-01-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-001 | 10570453 | 2028-03-28 | U-4562 | 2026-07-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-001 | 10570453 | 2028-03-28 | U-4563 | 2026-07-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-001 | 9157121 | 2030-04-05 | U-1674 | 2015-10-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-001 | 10563259 | 2030-07-24 | U-4562 | 2026-07-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-001 | 10563259 | 2030-07-24 | U-4563 | 2026-07-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-001 | 8652776 | 2030-08-31 | U-1685 | 2015-04-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-001 | 12606869 | 2030-09-22 | U-4504 | 2026-05-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-001 | 12606869 | 2030-09-22 | U-4505 | 2026-05-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-001 | 8999638 | 2030-10-28 | U-1674 | 2015-04-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-001 | 9074255 | 2030-12-17 | U-1674 | 2015-07-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-001 | 9072742 | 2031-01-16 | U-1674 | 2015-07-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-001 | 9074256 | 2031-02-10 | U-1674 | 2015-07-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-001 | 9074254 | 2031-12-28 | U-1674 | 2015-07-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-002 | 8586610 | 2027-11-02 | U-1625 | 2015-01-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-002 | 10570453 | 2028-03-28 | U-4562 | 2026-07-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-002 | 10570453 | 2028-03-28 | U-4563 | 2026-07-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-002 | 9157121 | 2030-04-05 | U-1674 | 2015-10-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-002 | 10563259 | 2030-07-24 | U-4562 | 2026-07-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-002 | 10563259 | 2030-07-24 | U-4563 | 2026-07-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-002 | 8652776 | 2030-08-31 | U-1685 | 2015-04-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-002 | 12606869 | 2030-09-22 | U-4504 | 2026-05-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-002 | 12606869 | 2030-09-22 | U-4505 | 2026-05-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-002 | 8999638 | 2030-10-28 | U-1674 | 2015-04-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-002 | 9074255 | 2030-12-17 | U-1674 | 2015-07-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-002 | 9072742 | 2031-01-16 | U-1674 | 2015-07-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-002 | 9074256 | 2031-02-10 | U-1674 | 2015-07-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-002 | 9074254 | 2031-12-28 | U-1674 | 2015-07-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-003 | 8586610 | 2027-11-02 | U-1625 | 2015-01-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-003 | 10570453 | 2028-03-28 | U-4562 | 2026-07-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-003 | 10570453 | 2028-03-28 | U-4563 | 2026-07-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-003 | 9157121 | 2030-04-05 | U-1674 | 2015-10-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-003 | 10563259 | 2030-07-24 | U-4562 | 2026-07-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-003 | 10563259 | 2030-07-24 | U-4563 | 2026-07-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-003 | 8652776 | 2030-08-31 | U-1685 | 2015-04-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-003 | 12606869 | 2030-09-22 | U-4504 | 2026-05-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-003 | 12606869 | 2030-09-22 | U-4505 | 2026-05-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-003 | 8999638 | 2030-10-28 | U-1674 | 2015-04-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-003 | 9074255 | 2030-12-17 | U-1674 | 2015-07-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022192-003 | 9072742 | 2031-01-16 | U-1674 | 2015-07-28 | caaa826d4ba7… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N022192-001 | I-939 | 2027-04-02 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022192-002 | I-939 | 2027-04-02 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022192-003 | I-939 | 2027-04-02 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022192-004 | I-939 | 2027-04-02 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022192-005 | I-939 | 2027-04-02 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022192-006 | I-939 | 2027-04-02 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022192-007 | I-939 | 2027-04-02 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N022192-001 | I-939 | 2027-04-02 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022192-002 | I-939 | 2027-04-02 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022192-003 | I-939 | 2027-04-02 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022192-004 | I-939 | 2027-04-02 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022192-005 | I-939 | 2027-04-02 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022192-006 | I-939 | 2027-04-02 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022192-007 | I-939 | 2027-04-02 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022192-001 | I-939 | 2027-04-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022192-002 | I-939 | 2027-04-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022192-003 | I-939 | 2027-04-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022192-004 | I-939 | 2027-04-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022192-005 | I-939 | 2027-04-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022192-006 | I-939 | 2027-04-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022192-007 | I-939 | 2027-04-02 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N022192-001 | I-939 | 2027-04-02 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022192-002 | I-939 | 2027-04-02 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022192-003 | I-939 | 2027-04-02 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022192-004 | I-939 | 2027-04-02 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022192-005 | I-939 | 2027-04-02 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022192-006 | I-939 | 2027-04-02 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022192-007 | I-939 | 2027-04-02 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022192-001 | I-939 | 2027-04-02 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022192-002 | I-939 | 2027-04-02 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022192-003 | I-939 | 2027-04-02 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022192-004 | I-939 | 2027-04-02 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022192-005 | I-939 | 2027-04-02 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022192-006 | I-939 | 2027-04-02 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022192-007 | I-939 | 2027-04-02 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022192-001 | I-939 | 2027-04-02 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022192-002 | I-939 | 2027-04-02 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022192-003 | I-939 | 2027-04-02 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022192-004 | I-939 | 2027-04-02 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022192-005 | I-939 | 2027-04-02 | b8a1b40f171c… |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c2441bbe-3ea0-4d2c-96a6-138bc08a4e8c | Product name | 2 | 20170213 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69189-0665-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-836b-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use FANAPT safely and effectively. See full prescribing information for FANAPT. FANAPT ® (iloperidone) tablets Initial U.S. Approval: 2009 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69189-0665-1 | Fanapt | 1 in 1 DOSE PACK | TABLET | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69189-0665 | FANAPT (ILOPERIDONE) TABLET [AVERA MCKENNAN HOSPITAL] | 1 | Legacy NDC, 1 package rows | 20170410_69d63a08-1920-427a-a967-2ffea04fd974.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FANAPT | ILOPERIDONE | Vanda Pharmaceuticals Inc. | 33f60b40-3fca-11de-8f56-0002a5d5c51b | 2026-05-06 | Boxed warning, Warnings, Adverse reactions | 022192 NDA022192 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 848742 | Fanapt 4 MG Oral Tablet | PSN | 69d63a08-1920-427a-a967-2ffea04fd974 | 1 |
| 848740 | iloperidone 4 MG Oral Tablet | PSN | 69d63a08-1920-427a-a967-2ffea04fd974 | 1 |
| 848742 | iloperidone 4 MG Oral Tablet [Fanapt] | SBD | 69d63a08-1920-427a-a967-2ffea04fd974 | 1 |
| 848740 | iloperidone 4 MG Oral Tablet | SCD | 69d63a08-1920-427a-a967-2ffea04fd974 | 1 |
| 848742 | Fanapt 4 MG Oral Tablet | SY | 69d63a08-1920-427a-a967-2ffea04fd974 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 69189-0665-1 | 69189066501 | 1 in 1 DOSE PACK | Historical |